HK1090051A1 - 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors - Google Patents

4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Info

Publication number
HK1090051A1
HK1090051A1 HK06110721A HK06110721A HK1090051A1 HK 1090051 A1 HK1090051 A1 HK 1090051A1 HK 06110721 A HK06110721 A HK 06110721A HK 06110721 A HK06110721 A HK 06110721A HK 1090051 A1 HK1090051 A1 HK 1090051A1
Authority
HK
Hong Kong
Prior art keywords
phenylsulfanyl
serotonin reuptake
reuptake inhibitors
tetrahydropyridine derivatives
tetrahydropyridine
Prior art date
Application number
HK06110721A
Other languages
English (en)
Inventor
Pueschl Ask
Bang-Andersen Benny
Jorgensen Morten
Juhl Karsten
Ruhland Thomas
Andersen Kim
Kehler Jan
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1090051(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1090051A1 publication Critical patent/HK1090051A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK06110721A 2003-04-04 2006-09-26 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors HK1090051A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300518 2003-04-04
PCT/DK2004/000243 WO2004087662A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
HK1090051A1 true HK1090051A1 (en) 2006-12-15

Family

ID=35432910

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110721A HK1090051A1 (en) 2003-04-04 2006-09-26 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Country Status (28)

Country Link
US (1) US20070173522A1 (xx)
EP (1) EP1613594B1 (xx)
JP (1) JP2006522029A (xx)
KR (1) KR20060021825A (xx)
CN (1) CN100384822C (xx)
AR (1) AR043964A1 (xx)
AT (1) ATE390413T1 (xx)
AU (1) AU2004226319A1 (xx)
BR (1) BRPI0408453A (xx)
CA (1) CA2521172A1 (xx)
CL (1) CL2004000730A1 (xx)
CO (1) CO5700777A2 (xx)
DE (1) DE602004012724T2 (xx)
DK (1) DK1613594T3 (xx)
EA (1) EA009282B1 (xx)
ES (1) ES2301979T3 (xx)
HK (1) HK1090051A1 (xx)
HR (1) HRP20080243T3 (xx)
IS (1) IS8007A (xx)
MX (1) MXPA05010678A (xx)
NO (1) NO20055205L (xx)
NZ (1) NZ541944A (xx)
PL (1) PL1613594T3 (xx)
PT (1) PT1613594E (xx)
SI (1) SI1613594T1 (xx)
UA (1) UA81300C2 (xx)
WO (1) WO2004087662A1 (xx)
ZA (1) ZA200507182B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406894T1 (de) 2003-04-04 2008-09-15 Lundbeck & Co As H 4-(2-phenylsulfanyl-phenyl)-piperidin-derivate als serotonin-wiederaufnahme-hemmer
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
UA98698C2 (xx) * 2008-03-03 2012-06-11 Х. Луннбек А/С Фенілсульфанілфеніл]піперидини та способи їх одержання$$фенилсульфанилфенил]пиперидины и способы их получения
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
EP2930171A1 (en) * 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
DE2802306A1 (de) * 1977-01-27 1978-08-10 Hoechst Ag Azacycloalkane, azacycloalkene und ihre derivate
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
GB8912971D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
GEP20043160B (en) * 1999-10-13 2004-01-26 Pfizer Products Inc Us Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
PT1246816E (pt) * 1999-12-30 2004-08-31 Lundbeck & Co As H Derivados de fenilpiperazina substituidos sua preparacao e utilizacao
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
EP1613594B1 (en) 2008-03-26
JP2006522029A (ja) 2006-09-28
CL2004000730A1 (es) 2005-02-18
SI1613594T1 (sl) 2008-08-31
NO20055205L (no) 2005-11-04
CN100384822C (zh) 2008-04-30
MXPA05010678A (es) 2005-12-12
EA009282B1 (ru) 2007-12-28
US20070173522A1 (en) 2007-07-26
EA200501579A1 (ru) 2006-04-28
ZA200507182B (en) 2006-12-27
WO2004087662A1 (en) 2004-10-14
CO5700777A2 (es) 2006-11-30
CA2521172A1 (en) 2004-10-14
KR20060021825A (ko) 2006-03-08
EP1613594A1 (en) 2006-01-11
IS8007A (is) 2005-08-29
BRPI0408453A (pt) 2006-04-04
CN1777585A (zh) 2006-05-24
ATE390413T1 (de) 2008-04-15
PL1613594T3 (pl) 2008-09-30
DE602004012724D1 (de) 2008-05-08
AU2004226319A1 (en) 2004-10-14
DE602004012724T2 (de) 2009-04-09
ES2301979T3 (es) 2008-07-01
AR043964A1 (es) 2005-08-17
DK1613594T3 (da) 2008-07-14
HRP20080243T3 (en) 2009-04-30
UA81300C2 (en) 2007-12-25
PT1613594E (pt) 2008-07-01
NZ541944A (en) 2008-05-30

Similar Documents

Publication Publication Date Title
HK1090051A1 (en) 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
EG25095A (en) Phenyl-piperazines derivatives as serotonin reuptake inhibitors.
ZA200410408B (en) N-substituted piperidine derivatives as serotonin receptor agents.
AP2006003558A0 (en) Polymorphic forms of 3-(4-amino-1oxo-1,3 dilhydro-isoindol-2-yl)-piperidine-2,6-dione.
IL172063A0 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
EP1809613A4 (en) PROCESSES FOR PRODUCING 2,6-DIARYLE PIPERIDINE DERIVATIVES
HK1093503A1 (en) Pyrido 2, 1-a-isoquinoline derivatives as ddp-IV inhibitors
PL364580A1 (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
ZA200610666B (en) Piperidine derivatives as NK, antagonists
IL172542A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
EP1870401A4 (en) SUBSTITUTE DERIVATIVE PIPERAZINE IN 1,4
IL172541A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosyliceramide synthase (gcs)
GB0314054D0 (en) Amide derivatives as selective serotonin re-uptake inhibitors
MXPA03009383A (es) DERIVADOS DE HETEROCICLIL ETER DE FENILO COMO INHIBIDORES DE LA REABSORCIoN DE SEROTONINA.
DE602004010385D1 (de) 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate
IS7901A (is) 4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
AU2002230665A1 (en) 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands
IS2676B (is) 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar
EP1592673A4 (en) NEW SUBSTITUTED 2,3-BENZODIAZEPINES DERIVATIVES
ZA200509132B (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120402